首页> 外文学位 >Analysis and modeling of noninvasive measurement of tissue chromophores by the Optical Pharmacokinetic System.
【24h】

Analysis and modeling of noninvasive measurement of tissue chromophores by the Optical Pharmacokinetic System.

机译:光学药代动力学系统对组织发色团的非侵入性测量的分析和建模。

获取原文
获取原文并翻译 | 示例

摘要

Efficient design of anti-cancer treatments involving radiation- and photo-sensitizing therapeutics requires knowledge of tissue-specific drug concentrations. This dissertation investigates the utility of the Optical Pharmacokinetic System (OPS), a fiber-optic based elastic-scattering spectroscopy device, to noninvasively quantitate concentrations of sensitizing compounds and hemoglobin within tissue in vivo.;The OPS was used to quantitate concentrations of motexafin gadolinium (MGd), in mouse tissues in vivo and in situ. An algorithm was developed to quantify MGd absorbance by integration of the MGd peak absorbance area, thereby relaxing the requirement that the extinction coefficient be known a priori. Concentrations measured by OPS were well-correlated with measurements by high-performance liquid chromatography (HPLC).;Compartmental pharmacokinetic models were developed from tissue-specific MGd concentrations measured by OPS and HPLC. Models predicted both rapid initial distribution and slow elimination of MGd in plasma, fast transport of MGd out of the skin, and MGd retention at long times in the tumor. In vivo tumor MGd concentrations measured by the OPS were estimated by a linear combination of the plasma, tumor, and skin PK profiles.;A theoretical analysis of the OPS measurement of tissue was conducted using a Monte Carlo (MC) model of light transport through tissue that included discrete blood vessels. Simulation results motivated extensions to a previous analysis algorithm, including: (1) a novel analytic functionality between mean photon path length and total absorption coefficient; and (2) incorporation of a vessel correction factor to account for the pigment packaging effect of discrete vessels on the OPS-estimated absorption coefficient. These extensions improved OPS-estimates of both silicon phthalocyanine (Pc4) and hemoglobin concentration in a mouse xenograft in vivo following photodynamic therapy (PDT).;Mathematical models were utilized to investigate in silico the sensitivity of the OPS to chronically and acutely hypoxic regions within tumor tissue. PDT-induced acute hypoxia occurred via simulation of the photodynamic reaction. Subsequent simulation of the OPS measurement suggested that the OPS may be sensitive to the presence of chronically hypoxic vessels (an OPS-estimated hemoglobin saturation of ≥57% indicated 6% of vessels hypoxic), but may have limited application to detection of acute hypoxia following PDT.
机译:涉及放射增敏和光敏治疗的抗癌治疗的有效设计需要了解组织特异性药物的浓度。本论文研究了基于光纤的弹性散射光谱仪光学药代动力学系统(OPS)在体内非侵入性定量敏化化合物和血红蛋白浓度的实用性;该OPS用于定量莫托沙芬g的浓度(MGd),在体内和原位在小鼠组织中。开发了一种算法,通过积分MGd峰吸收面积来量化MGd吸收,从而放宽了先验已知消光系数的要求。通过OPS测量的浓度与通过高效液相色谱(HPLC)测量的相关性很好。;根据通过OPS和HPLC测量的组织特异性MGd浓度建立了隔室药代动力学模型。模型预测了血浆中MGd的快速初始分布和缓慢消除,MGd从皮肤的快速运输以及MGd在肿瘤中的长期保留。由OPS测量的体内肿瘤MGd浓度是通过血浆,肿瘤和皮肤PK曲线的线性组合来估算的;组织的OPS测量的理论分析是使用蒙特卡洛(MC)光通过包括离散血管的组织。仿真结果推动了对先前分析算法的扩展,包括:(1)在平均光子路径长度和总吸收系数之间的新颖分析功能; (2)合并一个容器校正因子以解决离散容器对OPS估计吸收系数的颜料包装效应。这些扩展改善了光动力疗法(PDT)后体内小鼠异种移植物中硅酞菁(Pc4)和血红蛋白浓度的OPS估计值。;利用数学模型在计算机上研究了OPS对内部慢性和急性低氧区域的敏感性肿瘤组织。通过模拟光动力反应,发生了PDT诱导的急性缺氧。随后的OPS测量模拟表明,OPS可能对慢性低氧血管的存在敏感(OPS估计的血红蛋白饱和度≥57%表示<6%的低氧血管),但可能在检测急性低氧方面有局限性在PDT之后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号